Kingswood Wealth Advisors LLC bought a new stake in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 89,368 shares of the company’s stock, valued at approximately $3,140,000. Kingswood Wealth Advisors LLC owned 2.74% of Invesco Nasdaq Biotechnology ETF as of its most recent filing with the Securities & Exchange Commission.
Separately, Ascentis Independent Advisors bought a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 1st quarter valued at about $31,000.
Invesco Nasdaq Biotechnology ETF Stock Up 0.5%
NASDAQ IBBQ opened at $34.68 on Tuesday. Invesco Nasdaq Biotechnology ETF has a 52 week low of $26.00 and a 52 week high of $36.84. The firm has a market capitalization of $113.06 million, a P/E ratio of 17.03 and a beta of 0.60. The company has a 50-day moving average price of $34.99 and a 200-day moving average price of $31.36.
Invesco Nasdaq Biotechnology ETF Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Monday, September 21st were issued a $0.2304 dividend. The ex-dividend date of this dividend was Monday, September 21st. This is a positive change from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.0342. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.7%.
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
